ROCKLEY PHOTONICS HOLDINGS L (RKLY)

KYG7614L1095 - Common Stock

0.1924  +0.01 (+3.55%)

After market: 0.1851 -0.01 (-3.79%)

Fundamental Rating

2

Taking everything into account, RKLY scores 2 out of 10 in our fundamental rating. RKLY was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. RKLY has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RKLY is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

RKLY had negative earnings in the past year.
In the past year RKLY has reported a negative cash flow from operations.

1.2 Ratios

RKLY has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RKLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

RKLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
RKLY has more shares outstanding than it did 1 year ago.
The debt/assets ratio for RKLY has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -13.29, we must say that RKLY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -13.29, RKLY is doing worse than 83.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.29
ROIC/WACCN/A
WACC5.9%

2.3 Liquidity

RKLY has a Current Ratio of 2.13. This indicates that RKLY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, RKLY is doing worse than 76.19% of the companies in the same industry.
RKLY has a Quick Ratio of 2.13. This indicates that RKLY is financially healthy and has no problem in meeting its short term obligations.
RKLY's Quick ratio of 2.13 is in line compared to the rest of the industry. RKLY outperforms 46.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.15% over the past year.
The Revenue for RKLY has decreased by -40.23% in the past year. This is quite bad
EPS 1Y (TTM)17.15%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q125.93%
Revenue 1Y (TTM)-40.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q-69.77%

3.2 Future

The Earnings Per Share is expected to grow by 20.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 109.59% on average over the next years. This is a very strong growth
EPS Next Y15.64%
EPS Next 2Y26.89%
EPS Next 3Y20.33%
EPS Next 5YN/A
Revenue Next Year-52.4%
Revenue Next 2Y74.54%
Revenue Next 3Y109.59%
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RKLY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RKLY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RKLY's earnings are expected to grow with 20.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.89%
EPS Next 3Y20.33%

0

5. Dividend

5.1 Amount

RKLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ROCKLEY PHOTONICS HOLDINGS L

NYSE:RKLY (1/23/2023, 7:04:01 PM)

After market: 0.1851 -0.01 (-3.79%)

0.1924

+0.01 (+3.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap25.52M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)17.15%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y15.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-40.23%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y